FDA Outlines Policy for Overseeing Nanotechnology

The FDA suggests businesses to consult with them before launching nanotechnology products, but won’t make a judgment call in general on the technology.

Federal regulators want to hear from companies using tiny, engineered micro-particles in their products, part of an effort to stay abreast of the growing field of nanotechnology.

FDA Outlines Policy for Overseeing Nanotechnology | Inc.com.

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s